These Democrats would have to surmount political and legislative hurdles at a time when the realities of Medicaid expansion ...
Pharma marketers have more data, dashboards, research and AI tools than ever, yet getting to the insight that actually ...
Teva settles U.S. states' drug price-fixing case; FDA knocks potential Keytruda competitor; Johnson & Johnson acquires Ollin ...
As physicians increasingly turn to AI for answers, the OpenEvidence executive will unpack what happens when pharma's HCP ...
The Fingerpaint founder is betting that sports can do more for healthcare marketers than put a pharmaceutical logo on a ...
Oura’s telehealth acquisition muddies waters; Prostate cancer screening recommendations change for some men; Boston ...
The rule didn’t set a standard process for states to prove Native American status, allowing states to raise the threshold for ...
The cold and flu brand more than doubled its estimated TV ad spend, while daytime programming nearly matched prime time’s ...
Researchers with direct knowledge told KFF Health News that the Pan American Health Organization reached the conclusion this ...
Drugmakers largely achieved solid topline results in Q3. The more interesting story related to their respective ad spends.
Much of the midterm election cycle — and the blue wave — centered on Americans’ affordability concerns. Voters are fed up ...
Former Lilly employee alleges company promoted Mounjaro off-label; White House stands by FDA nominee Heidi Overton; The ...